Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

That is assuming CTIX does not get bought out in 24-36 months. The following trials could be up and running in 2015:

1. K against certain solid tumors (phase 2)
2. K + Cytarabine against AML (phase 1b)
3. K + Sunitinib against renal cancer (phase 2)
4. K against retinoblastoma (phase 2/3)
5. B-ABSSSI (phase 3)
6. B-OM (phase 2)
7. P (phase 2/3)

The following trials could be further down the road:

1. K against lymphoma and multiple myeloma
2. B against diabetic foot ulcer
3. B-Ocular
4. B-Otic
5. Defensin-mimetics against Gram negative bacteria
6. Defensin-mimetics against candidiasis

By 2016 we should get data for most of the trials. If the Big 3 works, how can any big pharma pass up this kind of pipepline?

Buffett is right to hold good companies for decades, CTIX might just prove to be a very long term hold.